Article
Future landscape of hepatitis C research - Basic, translational and clinical perspectives.
Journal of hepatology - 1 Oct 2016
Moradpour Darius, Grakoui Arash, Manns Michael P
Abstract excerpt
With the latest all-oral interferon- and ribavirin-free regimens based on direct acting antivirals against the hepatitis C virus (HCV), sustained virological response rates of >90% are achieved, which is equivalent to cure. This has become possible for all genotypes and all subgroups of patients, including many of the most difficult-to-treat populations so far. Since a prophylactic HCV vaccine is not yet...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
